• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Authors' reply.

作者信息

Scheiner Bernhard, Pinter Matthias

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.

出版信息

Aliment Pharmacol Ther. 2019 Jul;50(2):231-232. doi: 10.1111/apt.15334.

DOI:10.1111/apt.15334
PMID:31246367
Abstract
摘要

相似文献

1
Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Authors' reply.信函：晚期肝细胞癌中程序性细胞死亡蛋白-1（PD-1）靶向免疫疗法：来自国际多中心真实世界队列的疗效和安全性数据——问题多于答案。作者回复
Aliment Pharmacol Ther. 2019 Jul;50(2):231-232. doi: 10.1111/apt.15334.
2
Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers.信函：晚期肝细胞癌中程序性细胞死亡蛋白1（PD-1）靶向免疫疗法：来自一项国际多中心真实世界队列的疗效和安全性数据——问题多于答案
Aliment Pharmacol Ther. 2019 Jul;50(2):230. doi: 10.1111/apt.15322.
3
Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma-authors' reply.信函：程序性细胞死亡蛋白-1靶向免疫疗法治疗晚期肝细胞癌——作者回复
Aliment Pharmacol Ther. 2019 Aug;50(3):341-342. doi: 10.1111/apt.15368.
4
Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma.信函：程序性细胞死亡蛋白-1靶向免疫疗法治疗晚期肝细胞癌
Aliment Pharmacol Ther. 2019 Aug;50(3):340-341. doi: 10.1111/apt.15336.
5
Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives.肝细胞癌中的程序性细胞死亡蛋白 1（PD-1）/程序性死亡配体 1（PD-L1）轴：预后和治疗展望。
Clin Transl Oncol. 2019 Jun;21(6):702-712. doi: 10.1007/s12094-018-1975-4. Epub 2018 Nov 1.
6
Recent developments with immunotherapy for hepatocellular carcinoma.肝细胞癌免疫治疗的最新进展。
Expert Opin Biol Ther. 2018 Aug;18(8):905-910. doi: 10.1080/14712598.2018.1499722. Epub 2018 Jul 20.
7
Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply.信函：抗病毒治疗可降低慢性乙型肝炎相关肝细胞癌的发生率，包括低风险患者——问题多于答案。作者回复。
Aliment Pharmacol Ther. 2017 Jan;45(1):186-187. doi: 10.1111/apt.13859.
8
Overshadowed prospect of programmed cell death protein-1 (PD-1) inhibitor as monotherapy for patients with advanced hepatocellular carcinoma.程序性细胞死亡蛋白-1（PD-1）抑制剂单药治疗晚期肝细胞癌患者的前景黯然失色。
Biosci Trends. 2019;13(3):282-283. doi: 10.5582/bst.2019.01161.
9
Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma.钇-90放射性栓塞联合PD-1抑制剂治疗晚期肝细胞癌
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1799-1802. doi: 10.1007/s00270-018-1993-1. Epub 2018 May 29.
10
Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade: A promising immunotherapy for hepatocellular carcinoma?肿瘤相关调节性T细胞缺失与PD-1/PD-L1阻断联合应用：肝细胞癌一种有前景的免疫疗法？
Hepatobiliary Pancreat Dis Int. 2018 Apr;17(2):93-94. doi: 10.1016/j.hbpd.2018.03.001. Epub 2018 Mar 8.

引用本文的文献

1
Reactivation of Hepatitis B Virus Among Patients With Cancer Receiving Immunotherapy.接受免疫治疗的癌症患者中乙型肝炎病毒的再激活
J Immunother Precis Oncol. 2020 Sep 29;4(2):53-55. doi: 10.36401/JIPO-20-19. eCollection 2021 May.
2
Downregulation of MARC2 Promotes Immune Escape and Is Associated With Immunosuppression of Hepatocellular Carcinoma.MARC2的下调促进免疫逃逸并与肝细胞癌的免疫抑制相关。
Front Genet. 2022 Jan 31;12:790093. doi: 10.3389/fgene.2021.790093. eCollection 2021.